BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 28359847)

  • 1. Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease.
    Condello C; Stöehr J
    Neurobiol Dis; 2018 Jan; 109(Pt B):191-200. PubMed ID: 28359847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease.
    Cohen M; Appleby B; Safar JG
    Prion; 2016; 10(1):9-17. PubMed ID: 26809345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Amyloid Prions and the Pathobiology of Alzheimer's Disease.
    Watts JC; Prusiner SB
    Cold Spring Harb Perspect Med; 2018 May; 8(5):. PubMed ID: 28193770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.
    Lau HHC; Ingelsson M; Watts JC
    Acta Neuropathol; 2021 Jul; 142(1):17-39. PubMed ID: 32743745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial propagation of distinct strains of Aβ prions from Alzheimer's disease patients.
    Watts JC; Condello C; Stöhr J; Oehler A; Lee J; DeArmond SJ; Lannfelt L; Ingelsson M; Giles K; Prusiner SB
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10323-8. PubMed ID: 24982139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's disease.
    Condello C; Lemmin T; Stöhr J; Nick M; Wu Y; Maxwell AM; Watts JC; Caro CD; Oehler A; Keene CD; Bird TD; van Duinen SG; Lannfelt L; Ingelsson M; Graff C; Giles K; DeGrado WF; Prusiner SB
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E782-E791. PubMed ID: 29311311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease.
    Catania M; Di Fede G
    Prog Mol Biol Transl Sci; 2020; 175():213-237. PubMed ID: 32958234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
    Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
    Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transmission of pathogenic protein aggregates in Alzheimer's disease].
    Schwarzman AL; Sarantseva SV
    Mol Biol (Mosk); 2017; 51(3):418-422. PubMed ID: 28707657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease and the amyloid β-protein.
    Walsh DM; Teplow DB
    Prog Mol Biol Transl Sci; 2012; 107():101-24. PubMed ID: 22482449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.
    Stöhr J; Watts JC; Mensinger ZL; Oehler A; Grillo SK; DeArmond SJ; Prusiner SB; Giles K
    Proc Natl Acad Sci U S A; 2012 Jul; 109(27):11025-30. PubMed ID: 22711819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates.
    Venkataramani V; Wirths O; Budka H; Härtig W; Kovacs GG; Bayer TA
    J Alzheimers Dis; 2012; 29(2):361-71. PubMed ID: 22232007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer's disease.
    Liu H; Kim C; Haldiman T; Sigurdson CJ; Nyström S; Nilsson KPR; Cohen ML; Wisniewski T; Hammarström P; Safar JG
    J Biol Chem; 2021 Nov; 297(5):101267. PubMed ID: 34599965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
    Viola KL; Klein WL
    Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion-like Mechanisms in Alzheimer's Disease.
    Yin RH; Tan L; Jiang T; Yu JT
    Curr Alzheimer Res; 2014; 11(8):755-64. PubMed ID: 25212914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Fyn Kinase in Alzheimer's Disease.
    Nygaard HB
    Biol Psychiatry; 2018 Feb; 83(4):369-376. PubMed ID: 28709498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta Amyloid Hallmarks: From Intrinsically Disordered Proteins to Alzheimer's Disease.
    Korsak M; Kozyreva T
    Adv Exp Med Biol; 2015; 870():401-21. PubMed ID: 26387111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aβ seeds and prions: How close the fit?
    Rasmussen J; Jucker M; Walker LC
    Prion; 2017 Jul; 11(4):215-225. PubMed ID: 28657440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.